Goldman Sachs issued an update on ADH today and increased its 12 month price target to $2.80 based on an improved EPS to $0.21 with a modest P/E ratio of 13.3x
Catalysts to the increase were stronger than expected sales, on-line offer, Mocka acquisition and DC project delivering from FY'21.
Ann: ADH Trading Update and FY20 Group Sales Guidance, page-16
Add ADH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.01 |
Change
0.020(1.01%) |
Mkt cap ! $353.4M | |||
| Open | High | Low | Value | Volume |
| $1.99 | $2.04 | $1.95 | $866.6K | 437.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3907 | $2.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.01 | 1502 | 1 |
View Market Depth
| Last trade - 16.10pm 14/10/2024 (20 minute delay) ? |
| ADH (ASX) Chart |